Joshua Olson

A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection

V. Nizet, R. Johnson, M. Köckritz-Blickwede, 2012, Journal of Molecular Medicine.

Antibacterial drug leads targeting isoprenoid biosynthesis

William Sinko, J Andrew McCammon, Steffen Lindert, 2012, Proceedings of the National Academy of Sciences.

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

Michael R. Yeaman, Abhay Dhand, V. Nizet, 2013, Journal of Molecular Medicine.

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

Michael D. Burkart, Manfred Rohde, V. Nizet, 2015, EBioMedicine.